Literature DB >> 28099213

Hydroxychloroquine-Induced Erythema Multiforme.

Nour Abou Assalie1, Robert Durcan, Laura Durcan, Michelle A Petri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28099213      PMCID: PMC5321779          DOI: 10.1097/RHU.0000000000000417

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  22 in total

1.  Fatal toxic epidermal necrolysis associated with hydroxychloroquine.

Authors:  M Murphy; A J Carmichael
Journal:  Clin Exp Dermatol       Date:  2001-07       Impact factor: 3.470

2.  Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis.

Authors:  M J Leckie; R G Rees
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

3.  LUPUS ERYTHEMATOSUS AND ERYTHEMA MULTIFORME-LIKE LESIONS. A SYNDROME WITH CHARACTERISTIC IMMUNOLOGICAL ABNORMALITIES.

Authors:  N R ROWELL; J S BECK; J R ANDERSON
Journal:  Arch Dermatol       Date:  1963-08

Review 4.  Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.

Authors:  Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

5.  Delayed hypersensitivity to hydroxychloroquine manifested by two different types of cutaneous eruptions in the same patient.

Authors:  P Rojas Pérez-Ezquerra; M de Barrio Fernández; F J de Castro Martínez; F J Ruiz Hornillos; A Prieto García
Journal:  Allergol Immunopathol (Madr)       Date:  2006 Jul-Aug       Impact factor: 1.667

Review 6.  Lupus erythematosus associated with erythema multiforme: does Rowell's syndrome exist?

Authors:  A R Shteyngarts; M R Warner; C Camisa
Journal:  J Am Acad Dermatol       Date:  1999-05       Impact factor: 11.527

7.  Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort.

Authors:  L A González; G J Pons-Estel; J Zhang; L M Vilá; J D Reveille; Graciela S Alarcón
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

8.  Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

Authors:  J A James; X R Kim-Howard; B F Bruner; M K Jonsson; M T McClain; M R Arbuckle; C Walker; G J Dennis; J T Merrill; J B Harley
Journal:  Lupus       Date:  2007       Impact factor: 2.911

Review 9.  Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes.

Authors:  J C Huff; W L Weston; M G Tonnesen
Journal:  J Am Acad Dermatol       Date:  1983-06       Impact factor: 11.527

10.  Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine.

Authors:  Aisha Lateef; Kong-Bing Tan; Tang Ching Lau
Journal:  Clin Rheumatol       Date:  2009-08-30       Impact factor: 2.980

View more
  6 in total

Review 1.  Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.

Authors:  Sairaj Satarker; Tejas Ahuja; Madhavan Nampoothiri; Madhuparna Banerjee; Vignesh Balaji E; Shagun Dogra; Tushar Agarwal
Journal:  Curr Pharmacol Rep       Date:  2020-08-24

Review 2.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

3.  A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment.

Authors:  Abdullah Demirbaş; Ömer Faruk Elmas; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-06-26       Impact factor: 2.851

4.  Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review.

Authors:  Parnian Jamshidi; Bahareh Hajikhani; Mehdi Mirsaeidi; Hassan Vahidnezhad; Masoud Dadashi; Mohammad Javad Nasiri
Journal:  Front Med (Lausanne)       Date:  2021-02-16

Review 5.  Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge.

Authors:  Alina Dima; Ciprian Jurcut; François Chasset; Renaud Felten; Laurent Arnaud
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-02-14       Impact factor: 5.346

6.  [Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjögren syndrome: a case report].

Authors:  Ansumana Mohammed Keita; Mouna Zahlane; Laila Benjilali; Lamiaa Essaadouni
Journal:  Pan Afr Med J       Date:  2021-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.